Free Family Medicine CME 2017‑2018 | CMEList.com

 


Pharmacotherapy of Obesity: Practical Applications for Clinical Care Free Diabetes CME
Live online June 7, 2017 and available on demand through December 7, 2017.
Posted by...Bernard Sklar, MD.
Free Obesity CME Credit hours..1.0.
CME Credits Awarded by....Boston University School of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for family physicians, internists, endocrinologists, nurse practitioners, physician assistants and other health care providers of people who may be obese and need pharmacotherapeutic interventions.
Educational material updated....June 7, 2017.
Expiration of CME credit...December 7, 2017.
Financial Support...Novo Nordisk.
After viewing the three presentations of Pharmacotherapy of Obesity: Practical Applications for Clinical Care, you will be better able to:
• Identify obesity as a disease, not a behavioral problem, and consider the implications of that paradigm shift on attitudes toward treating the condition
• Identify indications that lifestyle interventions have not been sufficient to result in weight loss
• Describe the pharmacology of, and indications for, the use of the currently available medications for chronic weight management
• Describe ongoing management of people using anti-obesity medications, including means to gauge both therapeutic efficacy or the need to consider bariatric surgery

Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 Posted by...Bernard Sklar, MD.
Free Psychiatry CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free. 
Instruction Type....Slide-Video Lectures.
Target Audiences....Healthcare professionals specializing in family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with MDD or related psychiatric diseases.
Educational material last updated...July 18, 2017.
Expiration of CME credit...July 18, 2019.
Financial Support...Valeant.
Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 includes major findings about major depressive disorder from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice.
After reviewing Major Depressive Disorder (MDD), you will be able to:
• Recall the most impactful findings about Major Depressive Disorder (MDD) from the APA 2017 Annual meeting relating to MDD pathophysiology, progression, & prognosis.
• Describe the most impactful findings about MDD from the APA 2017 Annual meeting relating to using the similarities & differences between MDD & bereavement to inform good clinical care.
• Summarize the most impactful findings about MDD from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of MDD and apply them to patient cases.

Osteoporosis Management: Advances in Pharmacotherapy Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Free Osteoporosis CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free. 
Instruction Type....Slide-Video Lectures.
Target Audiences...Endocrinologists, geriatricians, internists; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in those areas of medicine and those who otherwise commonly care for patients with osteoporosis.
Educational material last updated...July 4, 2017.
Expiration of CME credit....July 4, 2019.
Financial Support...Amgen.
Topics covered in After viewing Osteoporosis Management: Advances in Pharmacotherapy, you will be able to:
• Apply the results of diagnostic imaging and pertinent past medical history to determine a given patient's diagnosis of osteoporosis or osteopenia
• Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention
• Identify investigational pharmacotherapeutic treatments for management of osteoporosis, and describe their mechanisms of action and likely place in therapy
• Describe the challenges associated with treating patients with osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, etc.) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care

Cardiovascular Disease, Diabetes, and Diabetes Treatments: Understanding the Interrelationships
Free Cardiology CME Free Diiabetes CME Live online March 1, 2017, (Sessions 1 and 2), and March 29, 2017 (Session 3), and available on demand through September 29 2017.
Posted by...Bernard Sklar, MD.
Free Cardiovascular and Diabetes CME Credit hours...3.0.
CME Credits Awarded by....University of Cincinnati.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care clinicians, diabetes specialists, cardiologists, as well as other health care providers who provide front-line glycemic management for type 2 diabetes (T2DM) and its comorbidities.
Educational material updated...March 29, 2017.
Expiration of CME credit...September 29 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC, and Novo Nordisk Inc.
This activity consists of three sessions, each of which should take approximately 1 hour to complete.
At the conclusion of Cardiovascular Disease, Diabetes, and Diabetes Treatments, you will be able to:
• Discuss the etiologic and pathophysiologic interconnections among the components of the cardiometabolic syndrome and the development of cardiovascular disease
• Identify pharmacological actions of antidiabetes medications that could potentially impact cardiovascular outcomes
• Describe the rationale for studying the cardiovascular impact of antidiabetes medications
• Compare and contrast antidiabetes pharmacotherapies which can optimize glycemic control and minimize adverse effects on cardiovascular risk and/or disease
• Discuss the efficacy and safety data for recent trials that examined the cardiovascular impact of antidiabetes medications
• Delineate critical assessments of recent cardiovascular outcomes trials for antidiabetes medications with regard to their evidence-based clinical implications

Updates in Alzheimer's Disease: An Expert Interview Series
Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Primary care providers, neurologists, gerontologists, radiologists, nuclear medicine physicians, and other health care professionals involved in the treatment of patients with Alzheimer's disease.
Educational material last updated...October 11th, 2016.
CME Credit Expires...October 10th, 2017.
Financial Support...Lilly.
Updates in Alzheimer's Disease consists of two brief lectures:
• Emerging Therapies for the Treatment of Alzheimer's Disease
• Alzheimer's Disease: Updates on Diagnostics and Early-stage Management
After competing Updates in Alzheimer's Disease, you should be better able to:
• Evaluate evidence-based strategies for the early diagnosis of Alzheimer's disease.
• Review the latest data of the pathophysiology and management strategies for pre-symptomatic and mild Alzheimer's disease.
• Evaluate the latest safety and efficacy data for new and emerging agents for the treatment of Alzheimer's disease.

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD
In order to get credit from ScientiaCME, you must first establish a username and password.